Back to today’s briefing

Story perspectives

New Blood Test Detects Pancreatic Cancer with 85% Accuracy

2/15/2025

37 4

Summary

Story summary

U.S. researchers have unveiled PAC-MANN, a groundbreaking blood test that identifies early-stage pancreatic ductal adenocarcinoma (PDAC) with an impressive 85% accuracy. Requiring just 8 microliters of blood and costing less than a penny per sample, this innovative test promises to enhance early detection and significantly improve treatment outcomes for those at high risk of pancreatic cancer.

1 of 1

Story summary

U.S. researchers have unveiled PAC-MANN, a groundbreaking blood test that identifies early-stage pancreatic ductal adenocarcinoma (PDAC) with an impressive 85% accuracy. Requiring just 8 microliters of blood and costing less than a penny per sample, this innovative test promises to enhance early detection and significantly improve treatment outcomes for those at high risk of pancreatic cancer.